Innoviva, Inc.INVANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR+4.4%
5Y CAGR-3.2%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+4.4%/yr
vs -19.8%/yr prior
5Y CAGR
-3.2%/yr
Recent acceleration
Acceleration
+24.2pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20253.17+4.5%
20243.03-10.3%
20233.38+21.4%
20222.79-22.9%
20213.61-3.1%
20203.73-32.1%
20195.49-18.6%
20186.74-3.5%
20176.99-20.9%
20168.83-